FDAnews
www.fdanews.com/articles/69798-nordic-capital-stake-purchase-values-nycomed-at-eur1-8-billion

Nordic Capital Stake Purchase Values Nycomed at EUR1.8 Billion

March 14, 2005

Nordic Capital Fund V has agreed to acquire a controlling interest in Danish pharmaceutical company Nycomed, Nycomed said in a statement Friday. DLJ Merchant Banking, part of CSFB's alternative capital division, and the Blackstone Group are selling the majority of their stake in the company to Nordic Capital, in a transaction that values Nycomed at EUR1.8 billion. The transaction will be paid in part with a EUR400 million pay-in-kind note that is being arranged by Credit Suisse First Boston and Goldman Sachs (GS).

iWon (http://money.iwon.com/jsp/nw/nwdt_rt.jsp?cat=USMARKET&src=704&feed=dji§ion=news&news_id=dji-00049920050311&date=20050311&alias=/alias/money/cm/nw)